Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have had tuberculosis (TB) bacteria identified from a body fluid or tissue sample through a lab test (such as PCR or culture), or who have been clinically diagnosed with TB based on exposure history, physical examination, imaging results, and/or tissue analysis
- People who have TB affecting areas outside the lungs, including the lining around the lungs (pleura), lymph nodes, bones or joints, voice box (larynx), lining around the heart (pericardium), parotid gland, abdominal organs, kidneys, reproductive or urinary tract, or TB that has spread throughout the body (miliary TB)
- People who have both lung and non-lung TB, where the main focus of the disease — based on symptoms and imaging — is outside the lungs
- People who are able and willing to provide written consent to participate before joining the trial
Who may not be able to join:
- People under 18 years of age
- People whose social or personal circumstances may make it difficult to participate fully in the study, such as an inability to understand the study content or procedures, unwillingness to cooperate, or anticipated difficulty completing the study due to physical health (note: language barriers alone may not be a barrier, as a translator may be involved — confirm with trial site)
- People who have a close personal or professional relationship with the study team, such as family members or colleagues from the same department
- People who are pregnant
- People who are under legal guardianship or custodianship
- People whose TB is mainly affecting the lungs
- People whose only site of TB is the central nervous system (brain and spinal cord)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +49 (221) 478-39680
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of blood biomarkers as diagnostic tools for EPTB (gene expression via RNA-seq and T-cell response based); Evaluation of blood biomarkers to predict treatment response or failure, and cure in EPTB
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.